NCT02055118 - Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 24, 2014

Primary Completion Date

September 28, 2017

Study Completion Date

September 28, 2017

Conditions

Hunter Syndrome

Interventions

BIOLOGICAL

idursulfase-IT

10mg

OTHER

No IT treatment

Standard of Care

Trial Locations (9)

Women's and Children's Hospital, 72 King William Road, North Adelaide

University of North Carolina, Chapel Hill

Hospital Infantil Universitario Niño Jesus, Madrid

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

Hôpital Femme Mère Enfant, Bron

Children's Hospital and Research Center at Oakland, Oakland

The Hospital for Sick Children, Toronto

Instituto Nacional de Pediatría, Coyoacán

Royal Manchester Children's Hospital, Manchester